IL2 and neoplasm: In peripheral blood and tumor tissue of patients with liver cancer, an increased level of regulatory T cells (Tregs) is found, which inhibit effector T cells through consuming IL-2, secreting inhibitory cytokines such as IL-10, TGF-β and IL-35 and expressing the co-inhibitory molecule CTLA-4 (92).